Literature DB >> 22802218

Diabetes mellitus Type 2--the new face of an old lady.

Katharina Timper1, Marc Y Donath.   

Abstract

Already 600 years before Christ, type 2 diabetes was known as a disease of elevated blood sugar levels associated with obesity. Since then, it appears, our understanding of the disease has not changed much, aside from the replacement of tasting the patients' urine by the measurement of plasma glucose and glycated haemoglobin levels (HbA1c) for its diagnosis and the discovery of some new drugs. Already, in those old days a physician from India named Sushrut described diabetes mellitus as a disease characterised by the passage of large amounts of urine and its "honey-like" taste and, noteworthy, as a disease that is mainly associated with obesity and a sedentary lifestyle, recommending physical activity as the primary treatment option. Although these milestone observations remain valid, major progress in the underlying pathogenesis of type 2 diabetes has been achieved showing a new face of this old disease and opening doors for novel treatment options. This review will highlight recent pathophysiological aspects of type 2 diabetes, actual diagnostic and treatment guidelines and discuss some possible upcoming new therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22802218     DOI: 10.4414/smw.2012.13635

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  7 in total

1.  [Analysis of type 2 diabetes-induced late effects based on administrative data of social insurance in Austria and implications for the evaluation of the DMP diabetes mellitus].

Authors:  Franziska Großschädl; Wolfgang Freidl; Willibald J Stronegger; Nathalie T Burkert; Johanna Muckenhuber; Éva Rásky
Journal:  Wien Med Wochenschr       Date:  2014-07-29

2.  SLC30A8 gene polymorphism (rs13266634 C/T) and type 2 diabetes mellitus in south Iranian population.

Authors:  Hossein Faghih; Saied-Reza Khatami; Negar Azarpira; Ali-Mohammad Foroughmand
Journal:  Mol Biol Rep       Date:  2014-01-22       Impact factor: 2.316

Review 3.  Islet inflammation in plain sight.

Authors:  M H Abdulreda; P-O Berggren
Journal:  Diabetes Obes Metab       Date:  2013-09       Impact factor: 6.577

4.  'Patient-centered care' for complex patients with type 2 diabetes mellitus-analysis of two cases.

Authors:  Jennifer M Hackel
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2013-10-17

5.  SLC30A8, CDKAL1, TCF7L2, KCNQ1 and IGF2BP2 are Associated with Type 2 Diabetes Mellitus in Iranian Patients.

Authors:  Kazem Vatankhah Yazdi; Seyed Mehdi Kalantar; Massoud Houshmand; Masoud Rahmanian; Masoud Reza Manaviat; Mohammad Reza Jahani; Behnam Kamalidehghan; Amir Almasi-Hashiani
Journal:  Diabetes Metab Syndr Obes       Date:  2020-03-24       Impact factor: 3.168

Review 6.  Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome-Review of Classical and New Compounds: Part-I.

Authors:  Raquel Vieira; Selma B Souto; Elena Sánchez-López; Ana López Machado; Patricia Severino; Sajan Jose; Antonello Santini; Ana Fortuna; Maria Luisa García; Amelia M Silva; Eliana B Souto
Journal:  Pharmaceuticals (Basel)       Date:  2019-10-10

Review 7.  Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention.

Authors:  Yanling Wu; Yanping Ding; Yoshimasa Tanaka; Wen Zhang
Journal:  Int J Med Sci       Date:  2014-09-06       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.